Abstract
The pharmacology, pharmacokinetics, clinical efficacy, adverse effects, and dosage and administration of mirtazapine are reviewed. Mirtazapine is a new anti-depressant that blocks presynaptic alpha 2-adrenergic receptors and postsynaptic serotonin type 2 and type 3 receptors. Mirtazapine has FDA-approved labeling for treatment of depression. Limited data suggest it may also have beneficial anxiolytic and sedative effects. The drug is rapidly and completely absorbed after oral administration. It is biotransformed by hepatic demethylation and is suitable for once-daily doses. In several clinical trials, patients receiving mirtazapine showed significantly greater improvement as measured by scores on the Hamilton Rating Scale for Depression (HAM-D) compared with patients receiving placebo. Mirtazapine has been shown to be equally efficacious as amitriptyline, clomipramine, and doxepin as assessed by scores on the HAM-D or other depression rating scales. Mirtazapine is well tolerated. The most commonly reported adverse effects associated with mirtazapine are somnolence, increased appetite, weight gain, and dizziness. Few drug-drug interactions have been reported. The recommended starting dosage is 15 mg/day administered in a single ...Continue Reading
Citations
Jun 16, 2001·The American Journal of Hospice & Palliative Care·M P DavisJ Lycan
Sep 14, 2001·Journal of the American Geriatrics Society·L C Hutchison
Sep 6, 2002·Canadian Journal of Psychiatry. Revue Canadienne De Psychiatrie·Sang-Yeol LeeSuck-Che Choi
Feb 23, 2008·Critical Reviews in Clinical Laboratory Sciences·Sarah M R WilleWilly E E Lambert
Dec 20, 2011·Psychiatry and Clinical Neurosciences·Young Min Lee, Kyoung-Uk Lee
Dec 25, 2013·Psychosomatic Medicine·Misty A W HawkinsJesse C Stewart
Jan 25, 2003·Journal of Clinical Psychopharmacology·Pierre V TranWilliam Z Potter
Oct 19, 2002·Drug Metabolism and Disposition : the Biological Fate of Chemicals·Joanna D MoodyCarl E Cerniglia
Jun 26, 2003·Epilepsia·John J Barry
Apr 16, 2004·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Mellar P DavisSusan B LeGrand
Oct 14, 2008·Electrophoresis·Fernando José Malagueño de SantanaPierina Sueli Bonato
Mar 11, 2008·Human Psychopharmacology·A Ender AltintoprakGul Kitapcioglu
Feb 24, 2006·Canadian Journal of Psychiatry. Revue Canadienne De Psychiatrie·Jianhua ShenColin M Shapiro
Mar 22, 2003·Expert Review of Anticancer Therapy·Mellar P DavisRuth Lagman
Sep 6, 2002·Canadian Journal of Psychiatry. Revue Canadienne De Psychiatrie·G Abraham
Mar 7, 2006·Pharmacogenomics·Johannes PoppWerner Steimer
Feb 22, 2012·Biomedical Chromatography : BMC·Ney Carter BorgesRonilson Agnaldo Moreno
Mar 25, 2016·International Journal of Molecular Sciences·Michael Joseph LaveryGil Yosipovitch
Jul 28, 2016·American Journal of Clinical Dermatology·Carolyn StullGil Yosipovitch
Jun 4, 2016·Journal of Palliative Medicine·Shiao Yen Khoo, Nicky Quinlan
Apr 1, 2009·Bioanalysis·Fernando José Malagueño de SantanaPierina Sueli Bonato
Jul 24, 2014·The Journal of Cardiovascular Nursing·Misty A W HawkinsJoel W Hughes
Jul 1, 2017·Daru : Journal of Faculty of Pharmacy, Tehran University of Medical Sciences·Sanaz JamshidfarMohammadreza Rouini
Mar 23, 2000·Progress in Neurobiology·P GareriG De Sarro
Dec 7, 2000·Journal of Pharmaceutical and Biomedical Analysis·N Karaşen, S Altinöz
Dec 3, 2003·Brain Research·M Laura CuffiJavier Forn